Ramsco's Women Empowerment Initiative Recognized Among Top BRICS Businesswomen Practices for 2025    Egypt, Elsewedy review progress on Ain Sokhna phosphate complex    Gold prices end July with modest gains    Pakistan says successfully concluded 'landmark trade deal' with US    Egypt's FM, US envoy discuss Gaza ceasefire, Iran nuclear talks    Modon Holding posts AED 2.1bn net profit in H1 2025    Egypt's Electricity Ministry says new power cable for Giza area operational    Egypt's Al-Sisi, Italian defence minister discuss Gaza, security cooperation    Egypt's FM discusses Gaza, Nile dam with US senators    Aid airdrops intensify as famine deepens in Gaza amid mounting international criticism    Health minister showcases AI's impact on healthcare at Huawei Cloud Summit    On anti-trafficking day, Egypt's PM calls fight a 'moral and humanitarian duty'    Federal Reserve maintains interest rates    Egypt strengthens healthcare partnerships to enhance maternity, multiple sclerosis, and stroke care    Egypt keeps Gaza aid flowing, total tops 533,000 tons: minister    Indian Embassy to launch cultural festival in Assiut, film fest in Cairo    Egyptian aid convoy heads toward Gaza as humanitarian crisis deepens    Culture minister launches national plan to revive film industry, modernise cinematic assets    Rafah Crossing 'never been closed for one day' from Egypt: PM    I won't trade my identity to please market: Douzi    Two militants killed in foiled plot to revive 'Hasm' operations: Interior ministry    Egypt's EHA, Huawei discuss enhanced digital health    Egypt, Oman discuss environmental cooperation    Egypt's EDA explores pharma cooperation with Belarus    Foreign, housing ministers discuss Egypt's role in African development push    Egypt reveals heritage e-training portal    Three ancient rock-cut tombs discovered in Aswan    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Egypt's Irrigation Minister urges scientific cooperation to tackle water scarcity    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Ibnsina Pharma targets 26% market share as it plans expansion
Company working in full swing to develop its distribution network
Published in Daily News Egypt on 25 - 03 - 2018

Ibnsina Pharma is planning to increase its market share to 26% from its current level of 20% in the coming five years, the company's managing director, Amr Abdel Gawad, told Daily News Egypt.
"We are planning to pump new investments ranging between EGP 150m and EGP 200m into the Egyptian market over the next five years," Abdel Gawad added, noting that the company's total investments in the North African nation would climb to EGP 700m.
The pharmaceutical firm is also planning to expand by setting up new branches and developing its distribution network, in addition to boosting sales from government auctions, which recorded around EGP 1bn in 2017.
The EGX-listed company is also seeking to develop its pharmaceutical portfolio through current negotiations with several international firms to distribute their products in the Egyptian market, Abdel Gawad indicated.
Ibnsina signed two new contracts with Denmark-based Novo Nordisk on Wednesday to distribute more than 20 medicines to cure diabetes, haemophilia, and growth disorders.
Previously reliant on one public-sector distribution company and one private distribution company, Novo Nordisk will join a group of over 325 domestic and international suppliers who rely on Ibnsina Pharma to distribute their products to over 39,000 pharmacies, retail chains, wholesalers, and public and private hospitals across Egypt.
"We are incredibly proud and excited by this new opportunity to distribute Novo Nordisk's life-saving diabetes care, and haemophilia and growth disorder products across Egypt," said Mohsen Mahgoub, chairperson of Ibnsina Pharma.
"Our primary objective is leveraging our distribution network to provide much-needed access to medication and diabetes care products, which are essential drugs in Egypt. At Ibnsina Pharma, our commitment to maintaining high operating standards and serving as a one-stop shop providing storage, distribution, and value-added marketing services has allowed us to become highly successful in the market and a distributor of choice for many suppliers from both Egypt and abroad," he added.
In preparation for distributing this new array of medical products, Ibnsina Pharma invested EGP 2m in additional warehousing facilities and allocated 28 specialised trucks to deliver Novo Nordisk's cold-chain products.
Currently, the company has a total of 55 operational sites across the country.
As part of the conditions to obtain these new contracts, Ibnsina Pharma passed Novo Nordisk's due diligence and operational audit to meet international standards.
"This expansion is made possible by our successful IPO, conducted in the fourth quarter of 2017, which was about 18 times oversubscribed. Adding Novo Nordisk's high-demand products to our portfolio will continue to drive our profits and feed into our long-term plan for growth," Mahgoub asserted.
The audited financial statements of Ibnsina Pharma showed a 67.2% year-over-year growth in profits for 2017.
Net profit reached EGP 170.14m last year, versus EGP 101.75m a year earlier, the company said in a filing to the EGX.
Revenues rose to around EGP 9.82bn in 2017, compared to EGP 7.4bn in 2016.
The company announced that it would not distribute cash dividends to shareholders for 2017.


Clic here to read the story from its source.